Repligen's EBIT per Share for the
three
months ended in Mar. 2024 was $0.12.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.64.
During the past 12 months, the average EBIT per Share Growth Rate of Repligen was -103.30% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -31.00% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 12.10% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 13.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Repligen's EBIT per Share or its related term are showing as below:
RGEN'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -82.4 Med: 9.1 Max: 74.2
Current: -31
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Repligen was 74.20% per year. The lowest was -82.40% per year. And the median was 9.10% per year.
RGEN's 3-Year EBIT Growth Rate is ranked worse than 85.14% of 727
companies
in the Medical Devices & Instruments industry
Industry Median: 5.9
vs RGEN: -31.00
Repligen's EBIT for the
three
months ended in Mar. 2024 was $7.0 Mil.
Repligen EBIT per Share Historical Data
The historical data trend for Repligen's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.64
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Repligen (NAS:RGEN) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Repligen EBIT per Share Related Terms
Thank you for viewing the detailed overview of Repligen's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
RGEN has been successfully added to your 